{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Deferoxamine", "Ferricyanide", "Iron nitrosyl hemoglobin", "Nitric oxide"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32828952", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "08", "Day": "20"}], "ELocationID": ["10.1016/j.freeradbiomed.2020.08.004", "S0891-5849(20)31199-0"], "Journal": {"ISSN": "1873-4596", "JournalIssue": {"Volume": "160", "PubDate": {"Year": "2020", "Month": "Nov", "Day": "20"}}, "Title": "Free radical biology & medicine", "ISOAbbreviation": "Free Radic Biol Med"}, "ArticleTitle": "Deferoxamine produces nitric oxide under ferricyanide oxidation, blood incubation, and UV-irradiation.", "Pagination": {"StartPage": "458", "EndPage": "470", "MedlinePgn": "458-470"}, "Abstract": {"AbstractText": ["Deferoxamine (DFO), an iron chelator, is used therapeutically for the removal of excess iron in multiple clinical conditions such as beta thalassemia and intracerebral hemorrhage. DFO is also used as an iron chelator and hypoxia-mimetic agent in in vivo and in vitro basic research. Here we unexpectedly discover DFO to be a nitric oxide (NO) precursor in experiments where it was intended to act as an iron chelator. Production of NO from aqueous solutions of DFO was directly observed by ozone-based chemiluminescence using a ferricyanide-based assay and was confirmed by electron paramagnetic resonance (EPR). DFO also produced NO following exposure to ultraviolet light, and its incubation with sheep adult and fetal blood resulted in considerable formation of iron nitrosyl hemoglobin, as confirmed by both visible spectroscopy and EPR. These results suggest that experiments using DFO can be confounded by concomitant production of NO, and offer new insight into some of DFO's unexplained clinical side effects such as hypotension."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lawrence D Longo Center for Perinatal Biology and Department of Pediatrics, Loma Linda University, 11175 Campus Street, Loma Linda, CA, 92354, USA."}], "LastName": "Mukosera", "ForeName": "George T", "Initials": "GT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lawrence D Longo Center for Perinatal Biology and Department of Pediatrics, Loma Linda University, 11175 Campus Street, Loma Linda, CA, 92354, USA."}], "LastName": "Liu", "ForeName": "Taiming", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lawrence D Longo Center for Perinatal Biology and Department of Pediatrics, Loma Linda University, 11175 Campus Street, Loma Linda, CA, 92354, USA."}], "LastName": "Manaen", "ForeName": "Meshach", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of California-Riverside 501 Big Springs Road, Riverside, CA 92521, USA."}], "LastName": "Zhu", "ForeName": "Lingchao", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lawrence D Longo Center for Perinatal Biology and Department of Pediatrics, Loma Linda University, 11175 Campus Street, Loma Linda, CA, 92354, USA."}], "LastName": "Power", "ForeName": "Gordon", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lawrence D Longo Center for Perinatal Biology and Department of Pediatrics, Loma Linda University, 11175 Campus Street, Loma Linda, CA, 92354, USA."}], "LastName": "Schroeder", "ForeName": "Hobe", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lawrence D Longo Center for Perinatal Biology and Department of Pediatrics, Loma Linda University, 11175 Campus Street, Loma Linda, CA, 92354, USA. Electronic address: abblood@llu.edu."}], "LastName": "Blood", "ForeName": "Arlin B", "Initials": "AB"}], "GrantList": [{"GrantID": "P01 HD083132", "Acronym": "HD", "Agency": "NICHD NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL095973", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Free Radic Biol Med", "NlmUniqueID": "8709159", "ISSNLinking": "0891-5849"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ferricyanides"}, {"RegistryNumber": "0", "NameOfSubstance": "Iron Chelating Agents"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "J06Y7MXW4D", "NameOfSubstance": "Deferoxamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Deferoxamine"}, {"QualifierName": [], "DescriptorName": "Ferricyanides"}, {"QualifierName": [], "DescriptorName": "Iron Chelating Agents"}, {"QualifierName": [], "DescriptorName": "Nitric Oxide"}, {"QualifierName": [], "DescriptorName": "Sheep"}, {"QualifierName": [], "DescriptorName": "Ultraviolet Rays"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Adgent Margaret A., Squadrito Giuseppe L., Ballinger Carol A., Krzywanski David M., Lancaster Jack R., and Postlethwait Edward M.. 2012. \u201cDesferrioxamine Inhibits Protein Tyrosine Nitration: Mechanisms and Implications.\u201d Free Radical Biology & Medicine 53 (4): 951\u201361.", "ArticleIdList": ["PMC3462664", "22705369"]}, {"Citation": "Bazylinski Dennis A., and Hollocher Thomas C.. 1985. \u201cMetmyoglobin and Methemoglobin as Efficient Traps for Nitrosyl Hydride (nitroxyl) in Neutral Aqueous Solution.\u201d Journal of the American Chemical Society 107 (26): 7982\u201386."}, {"Citation": "Bensaid Samir, Fabre Claudine, Fourneau Julie, and Cieniewski-Bernard Caroline. 2019. \u201cImpact of Different Methods of Induction of Cellular Hypoxia: Focus on Protein Homeostasis Signaling Pathways and Morphology of C2C12 Skeletal Muscle Cells Differentiated into Myotubes.\u201d Journal of Physiology and Biochemistry 75 (3): 367\u201377.", "ArticleIdList": ["31267382"]}, {"Citation": "Blood Arlin B., Tiso Mauro, Verma Shilpa T., Lo Jennifer, Joshi Mahesh S., Azarov Ivan, Longo Lawrence D., Gladwin Mark T., Kim-Shapiro Daniel B., and Power Gordon G.. 2009. \u201cIncreased Nitrite Reductase Activity of Fetal versus Adult Ovine Hemoglobin.\u201d American Journal of Physiology. Heart and Circulatory Physiology 296 (2): H237\u201346.", "ArticleIdList": ["PMC2643889", "19028797"]}, {"Citation": "Bosworth Charles A., Toledo Jos\u00e9 C. Jr, Zmijewski Jaroslaw W., Li Qian, and Lancaster Jack R. Jr. 2009. \u201cDinitrosyliron Complexes and the Mechanism(s) of Cellular Protein Nitrosothiol Formation from Nitric Oxide.\u201d Proceedings of the National Academy of Sciences of the United States of America 106 (12): 4671\u201376.", "ArticleIdList": ["PMC2660757", "19261856"]}, {"Citation": "Davies MJ, Donkor R, Dunster CA, Gee CA, Jonas S, and Willson RL. 1987. \u201cDesferrioxamine (Desferal) and Superoxide Free Radicals. Formation of an Enzyme-Damaging Nitroxide.\u201d Biochemical Journal 246 (3): 725\u201329.", "ArticleIdList": ["PMC1148337", "2825650"]}, {"Citation": "Dayani Pouya N., Bishop Maria C., Black Keith, and Zeltzer Paul M.. 2004. \u201cDesferoxamine (DFO)--Mediated Iron Chelation: Rationale for a Novel Approach to Therapy for Brain Cancer.\u201d Journal of Neuro-Oncology 67 (3): 367\u201377.", "ArticleIdList": ["15164994"]}, {"Citation": "Fritsche G, Larcher C, Schennach H, and Weiss G. 2001. \u201cRegulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense against Plasmodium Falciparum Infection.\u201d The Journal of Infectious Diseases 183 (9): 1388\u201394.", "ArticleIdList": ["11294671"]}, {"Citation": "Gladwin Mark T., Shelhamer James H., Ognibene Frederick P., Pease-Fye Margaret E., Nichols James S., Link Beth, Patel Daksesh B., et al. 2002. \u201cNitric Oxide Donor Properties of Hydroxyurea in Patients with Sickle Cell Disease.\u201d British Journal of Haematology 116 (2): 436\u201344.", "ArticleIdList": ["11841449"]}, {"Citation": "Glover RE, Ivy ED, Orringer EP, Maeda H, and Mason RP. 1999. \u201cDetection of Nitrosyl Hemoglobin in Venous Blood in the Treatment of Sickle Cell Anemia with Hydroxyurea.\u201d Molecular Pharmacology 55 (6): 1006\u201310.", "ArticleIdList": ["10347241"]}, {"Citation": "Gumber Manoj R., Kute Vivek B., Shah Pankaj R., Vanikar Aruna V., Patel Himanshu V., Balwani Manish R., Ghuge Pramod P., and Trivedi Hargovind L.. 2013. \u201cSuccessful Treatment of Severe Iron Intoxication with Gastrointestinal Decontamination, Deferoxamine, and Hemodialysis.\u201d Renal Failure 35 (5): 729\u201331.", "ArticleIdList": ["23635030"]}, {"Citation": "G\u00fcnter K, Toupet C, and Schupp T. 1993. \u201cCharacterization of an Iron-Regulated Promoter Involved in Desferrioxamine B Synthesis in Streptomyces Pilosus: Repressor-Binding Site and Homology to the Diphtheria Toxin Gene Promoter.\u201d Journal of Bacteriology 175 (11): 3295\u20133302.", "ArticleIdList": ["PMC204726", "8501033"]}, {"Citation": "Guo Xi, Qi Xin, Li Hao, Duan Zhongxin, Wei Yang, Zhang Fan, Tian Meng, Ma Lu, and You Chao. 2019. \u201cDeferoxamine Alleviates Iron Overload and Brain Injury in a Rat Model of Brainstem Hemorrhage.\u201d World Neurosurgery 128 (August): e895\u2013904.", "ArticleIdList": ["31082547"]}, {"Citation": "Hamilton KO, Stallibrass L, Hassan I, Jin Y, Halleux C, and Mackay M. 1994. \u201cThe Transport of Two Iron Chelators, Desferrioxamine B and L1, across Caco-2 Monolayers.\u201d British Journal of Haematology 86 (4): 851\u201357.", "ArticleIdList": ["7918082"]}, {"Citation": "Hinojosa O, Jacks TJ, Calamari TA, and Thibodeaux DP. 1989. \u201cElectron Spin Resonance Study of the Relationship of UV Irradiation to Nitroxide Radical Formation in Desferrioxamine (Desferal) and Related Hydroxamate and Hydroxylamine Derivatives.\u201d Photochemistry and Photobiology 49 (1): 1\u20135.", "ArticleIdList": ["2541455"]}, {"Citation": "Huang Jinming, Hadimani Shreeshailkumar B., Rupon Jeremy W., Ballas Samir K., Kim-Shapiro Daniel B., and Bruce King S. 2002. \u201cIron Nitrosyl Hemoglobin Formation from the Reactions of Hemoglobin and Hydroxyurea.\u201d Biochemistry 41 (7): 2466\u201374.", "ArticleIdList": ["11841242"]}, {"Citation": "Huang Jinming, Sommers Erin M., Kim-Shapiro Daniel B., and King S. Bruce. 2002. \u201cHorseradish Peroxidase Catalyzed Nitric Oxide Formation from Hydroxyurea.\u201d Journal of the American Chemical Society 124 (13): 3473\u201380.", "ArticleIdList": ["11916434"]}, {"Citation": "Huang Jinming, Zou Zhou, Kim-Shapiro Daniel B., Ballas Samir K., and King S. Bruce. 2003. \u201cHydroxyurea Analogues as Kinetic and Mechanistic Probes of the Nitric Oxide Producing Reactions of Hydroxyurea and Oxyhemoglobin.\u201d Journal of Medicinal Chemistry 46 (17): 3748\u201353.", "ArticleIdList": ["12904079"]}, {"Citation": "Huang Zhi, Shiva Sruti, Kim-Shapiro Daniel B., Patel Rakesh P., Ringwood Lorna A., Irby Cynthia E., Huang Kris T., et al. 2005. \u201cEnzymatic Function of Hemoglobin as a Nitrite Reductase That Produces NO under Allosteric Control.\u201d The Journal of Clinical Investigation 115 (8): 2099\u20132107.", "ArticleIdList": ["PMC1177999", "16041407"]}, {"Citation": "Ikeda Yasumasa, Tajima Soichiro, Yoshida Sumiko, Yamano Noriko, Kihira Yoshitaka, Ishizawa Keisuke, Aihara Ken-Ichi, Tomita Shuhei, Tsuchiya Koichiro, and Tamaki Toshiaki. 2011. \u201cDeferoxamine Promotes Angiogenesis via the Activation of Vascular Endothelial Cell Function.\u201d Atherosclerosis 215 (2): 339\u201347.", "ArticleIdList": ["21315355"]}, {"Citation": "Jiang J, Jordan SJ, Barr DP, Gunther MR, Maeda H, and Mason RP. 1997. \u201cIn Vivo Production of Nitric Oxide in Rats after Administration of Hydroxyurea.\u201d Molecular Pharmacology 52 (6): 1081\u201386.", "ArticleIdList": ["9415718"]}, {"Citation": "Kenny Reece G., Ude Ziga, Docherty James R., and Marmion Celine J.. 2019. \u201cVorinostat and Belinostat, Hydroxamate-Based Anti-Cancer Agents, Are Nitric Oxide Donors.\u201d Journal of Inorganic Biochemistry 206 (December): 110981.", "ArticleIdList": ["32088592"]}, {"Citation": "Kim Jung Lim, Lee Dae-Hee, Na Yoo Jin, Kim Bo Ram, Jeong Yoon A., Lee Sun Il, Kang Sanghee, et al. 2016. \u201cIron Chelator-Induced Apoptosis via the ER Stress Pathway in Gastric Cancer Cells.\u201d Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 37 (7): 9709\u201319.", "ArticleIdList": ["26803514"]}, {"Citation": "King S. Bruce. 2004. \u201cNitric Oxide Production from Hydroxyurea.\u201d Free Radical Biology & Medicine 37 (6): 737\u201344.", "ArticleIdList": ["15304249"]}, {"Citation": "King S. Bruce. 2005. \u201cN-Hydroxyurea and Acyl Nitroso Compounds as Nitroxyl (HNO) and Nitric Oxide (NO) Donors.\u201d Current Topics in Medicinal Chemistry 5 (7): 665\u201373.", "ArticleIdList": ["16101427"]}, {"Citation": "Komarov Andrei M., Wink David A., Feelisch Martin, and Schmidt Harald H. H. W.. 2000. \u201cElectron-Paramagnetic Resonance Spectroscopy Using N-Methyl-D-Glucamine Dithiocarbamate Iron Cannot Discriminate between Nitric Oxide and Nitroxyl: Implications for the Detection of Reaction Products for Nitric Oxide Synthase.\u201d Free Radical Biology and Medicine 28 (5): 739\u201342.", "ArticleIdList": ["10754269"]}, {"Citation": "Kontoghiorghe Christina N., and Kontoghiorghes George J.. 2016. \u201cEfficacy and Safety of Iron-Chelation Therapy with Deferoxamine, Deferiprone, and Deferasirox for the Treatment of Iron-Loaded Patients with Non-Transfusion-Dependent Thalassemia Syndromes.\u201d Drug Design, Development and Therapy 10 (January): 465\u201381.", "ArticleIdList": ["PMC4745840", "26893541"]}, {"Citation": "Lang Jiayan, Zhao Xiao, Wang Xiuchao, Zhao Ying, Li Yiye, Zhao Ruifang, Cheng Keman, et al. 2019. \u201cTargeted Co-Delivery of the Iron Chelator Deferoxamine and a HIF1\u03b1 Inhibitor Impairs Pancreatic Tumor Growth.\u201d ACS Nano 13 (2): 2176\u201389.", "ArticleIdList": ["30676731"]}, {"Citation": "Liu Taiming, Zhang Meijuan, Mukosera George T., Borchardt Dan, Li Qian, Tipple Trent E., Ahmed Abu Shufian Ishtiaq, Power Gordon G., and Blood Arlin B.. 2019. \u201cL-NAME Releases Nitric Oxide and Potentiates Subsequent Nitroglycerin-Mediated Vasodilation.\u201d Redox Biology. 10.1016/j.redox.2019.101238.", "ArticleIdList": ["10.1016/j.redox.2019.101238", "PMC6565607", "31200239"]}, {"Citation": "Liu Taiming, Zhang Meijuan, Terry Michael H., Schroeder Hobe, Wilson Sean M., Power Gordon G., Li Qian, Tipple Trent E., Borchardt Dan, and Blood Arlin B.. 2018. \u201cHemodynamic Effects of Glutathione-Liganded Binuclear Dinitrosyl Iron Complex: Evidence for Nitroxyl Generation and Modulation by Plasma Albumin.\u201d Molecular Pharmacology 93 (5): 427\u201337.", "ArticleIdList": ["PMC5878675", "29476040"]}, {"Citation": "Lockamy Virginia L., Huang Jinming, Shields Howard, Ballas Samir K., King S. Bruce, and Kim-Shapiro Daniel B.. 2003. \u201cUrease Enhances the Formation of Iron Nitrosyl Hemoglobin in the Presence of Hydroxyurea.\u201d Biochimica et Biophysica Acta (BBA) - General Subjects 1622 (2): 109\u201316.", "ArticleIdList": ["12880948"]}, {"Citation": "Maimon Eric, Samuni Amram, and Goldstein Sara. 2018. \u201cNitrogen Dioxide Reaction with Nitroxide Radical Derived from Hydroxamic Acids: The Intermediacy of Acyl Nitroso and Nitroxyl (HNO).\u201d The Journal of Physical Chemistry. A 122 (15): 3747\u201353.", "ArticleIdList": ["29608853"]}, {"Citation": "Mart\u00ednez-Romero Rub\u00e9n, Mart\u00ednez-Lara Esther, Aguilar-Quesada Roc\u00edo, Peralta Andre\u00edna, Oliver F. Javier, and Siles Eva. 2008. \u201cPARP-1 Modulates Deferoxamine-Induced HIF-1alpha Accumulation through the Regulation of Nitric Oxide and Oxidative Stress.\u201d Journal of Cellular Biochemistry 104 (6): 2248\u201360.", "ArticleIdList": ["18459142"]}, {"Citation": "McGann Patrick T., and Ware Russell E.. 2015. \u201cHydroxyurea Therapy for Sickle Cell Anemia.\u201d Expert Opinion on Drug Safety 14 (11): 1749\u201358.", "ArticleIdList": ["PMC5868345", "26366626"]}, {"Citation": "Meczynska Sylwia, Lewandowska Hanna, Sochanowicz Barbara, Sadlo Jaroslaw, and Kruszewski Marcin. 2008. \u201cVariable Inhibitory Effects on the Formation of Dinitrosyl Iron Complexes by Deferoxamine and Salicylaldehyde Isonicotinoyl Hydrazone in K562 Cells.\u201d Hemoglobin 32 (1\u20132): 157\u201363.", "ArticleIdList": ["18274993"]}, {"Citation": "Morehouse KM, Flitter WD, and Mason RP. 1987. \u201cThe Enzymatic Oxidation of Desferal to a Nitroxide Free Radical.\u201d FEBS Letters 222 (2): 246\u201350.", "ArticleIdList": ["2820803"]}, {"Citation": "Mukosera George T., Liu Taiming, Ahmed Abu Shufian Ishtiaq, Li Qian, Sheng Matilda H-C, Tipple Trent E., Baylink David J., Power Gordon G., and Blood Arlin B.. 2018. \u201cDetection of Dinitrosyl Iron Complexes by Ozone-Based Chemiluminescence.\u201d Nitric Oxide: Biology and Chemistry / Official Journal of the Nitric Oxide Society 79 (September): 57\u201367.", "ArticleIdList": ["PMC6277231", "30059767"]}, {"Citation": "Paolocci Nazareno, Jackson Matthew I., Lopez Brenda E., Miranda Katrina, Tocchetti Carlo G., Wink David A., Hobbs Adrian J., and Fukuto Jon M.. 2007. \u201cThe Pharmacology of Nitroxyl (HNO) and Its Therapeutic Potential: Not Just the Janus Face of NO.\u201d Pharmacology & Therapeutics 113 (2): 442\u201358.", "ArticleIdList": ["PMC3501193", "17222913"]}, {"Citation": "Piccioni Maria Grazia, Capone Carmela, Vena Flaminia, Valentina Del Negro Michele Carlo Schiavi, D\u2019Ambrosio Valentina, Giancotti Antonella, Smacchia Maria Paola, and Brunelli Roberto. 2020. \u201cUse of Deferoxamine (DFO) in Transfusion-Dependent \u03b2-Thalassemia during Pregnancy: A Retrospective Study.\u201d Taiwanese Journal of Obstetrics & Gynecology 59 (1): 120\u201322.", "ArticleIdList": ["32039778"]}, {"Citation": "Pieper GM, Gross GJ, and Kalyanaraman B. 1990. \u201cAn ESR Study of the Nitroxide Radical of Pentastarch-Conjugated Deferoxamine.\u201d Free Radical Biology & Medicine 9 (3): 211\u201318.", "ArticleIdList": ["2177027"]}, {"Citation": "Qing Wang Gai, Dong Yang Qi, Ping Tang Qing, Lai Li Guang, Fang Li Dong, Min Hu Wei, Xia Lian, and Heng Pei Yu. 2009. \u201cBrain Edema after Intracerebral Hemorrhage in Rats: The Role of Iron Overload and Aquaporin 4.\u201d Journal of Neurosurgery 110 (3): 462\u201368.", "ArticleIdList": ["19025353"]}, {"Citation": "Richardson D, Ponka P, and Baker E. 1994. \u201cThe Effect of the iron(III) Chelator, Desferrioxamine, on Iron and Transferrin Uptake by the Human Malignant Melanoma Cell.\u201d Cancer Research 54 (3): 685\u201389.", "ArticleIdList": ["8306330"]}, {"Citation": "Rimawi HS al-Sheyyab al-, M., Batieha A, el-Shanti H, and Abuekteish F. 1999. \u201cEffect of Desferrioxamine in Acute Haemolytic Anaemia of Glucose-6-Phosphate Dehydrogenase Deficiency.\u201d Acta Haematologica 101 (3): 145\u201348.", "ArticleIdList": ["10352334"]}, {"Citation": "Sahni, Hickok Jason R., and Thomas Douglas D.. 2018. \u201cNitric Oxide Reduces Oxidative Stress in Cancer Cells by Forming Dinitrosyliron Complexes.\u201d Nitric Oxide: Biology and Chemistry / Official Journal of the Nitric Oxide Society 76 (June): 37\u201344.", "ArticleIdList": ["PMC5916741", "29522907"]}, {"Citation": "Samuni Amram, and Goldstein Sara. 2011. \u201cOne-Electron Oxidation of Acetohydroxamic Acid: The Intermediacy of Nitroxyl and Peroxynitrite.\u201d The Journal of Physical Chemistry. A 115 (14): 3022\u201328.", "ArticleIdList": ["21425838"]}, {"Citation": "Samuni Yuval, Flores-Santana Wilmarie, Krishna Murali C., Mitchell James B., and Wink David A.. 2009. \u201cThe Inhibitors of Histone Deacetylase Suberoylanilide Hydroxamate and Trichostatin A Release Nitric Oxide upon Oxidation.\u201d Free Radical Biology & Medicine 47 (4): 419\u201323.", "ArticleIdList": ["PMC2730666", "19447172"]}, {"Citation": "Samuni Yuval, Wink David A., Krishna Murali C., Mitchell James B., and Goldstein Sara. 2014. \u201cSuberoylanilide Hydroxamic Acid Radiosensitizes Tumor Hypoxic Cells in Vitro through the Oxidation of Nitroxyl to Nitric Oxide.\u201d Free Radical Biology & Medicine 73 (August): 291\u201398.", "ArticleIdList": ["PMC7670884", "24880052"]}, {"Citation": "Selim Magdy. 2009. \u201cDeferoxamine Mesylate: A New Hope for Intracerebral Hemorrhage: From Bench to Clinical Trials.\u201d Stroke; a Journal of Cerebral Circulation 40 (3 Suppl): S90\u201391.", "ArticleIdList": ["19064798"]}, {"Citation": "Selim Magdy, Yeatts Sharon, Goldstein Joshua N., Gomes Joao, Greenberg Steven, Morgenstern Lewis B., Schlaug Gottfried, et al. 2011. \u201cSafety and Tolerability of Deferoxamine Mesylate in Patients with Acute Intracerebral Hemorrhage.\u201d Stroke; a Journal of Cerebral Circulation 42 (11): 3067\u201374.", "ArticleIdList": ["PMC3202043", "21868742"]}, {"Citation": "Singer Sylvia Titi, and Vichinsky Elliott P.. 1999. \u201cDeferoxamine Treatment during Pregnancy: Is It Harmful?\u201d American Journal of Hematology.", "ArticleIdList": ["9883802"]}, {"Citation": "Tenenbein M 1996. \u201cBenefits of Parenteral Deferoxamine for Acute Iron Poisoning.\u201d Journal of Toxicology. Clinical Toxicology 34 (5): 485\u201389.", "ArticleIdList": ["8800185"]}, {"Citation": "Thomas Douglas D., Corey Catherine, Hickok Jason, Wang Yinna, and Shiva Sruti. 2018. \u201cDifferential Mitochondrial Dinitrosyliron Complex Formation by Nitrite and Nitric Oxide.\u201d Redox Biology 15 (May): 277\u201383.", "ArticleIdList": ["PMC5975210", "29304478"]}, {"Citation": "Toledo Jos\u00e9 C. Jr, Bosworth Charles A., Hennon Seth W., Mahtani Harry A., Bergonia Hector A., and Lancaster Jack R. Jr. 2008. \u201cNitric Oxide-Induced Conversion of Cellular Chelatable Iron into Macromolecule-Bound Paramagnetic Dinitrosyliron Complexes.\u201d The Journal of Biological Chemistry 283 (43): 28926\u201333.", "ArticleIdList": ["PMC2570868", "18480062"]}, {"Citation": "Weiss G, Thuma PE, Mabeza G, Werner ER, Herold M, and Gordeuk VR. 1997. \u201cModulatory Potential of Iron Chelation Therapy on Nitric Oxide Formation in Cerebral Malaria.\u201d The Journal of Infectious Diseases 175 (1): 226\u201330.", "ArticleIdList": ["8985227"]}, {"Citation": "Westlin WF 1966. \u201cDeferoxamine in the Treatment of Acute Iron Poisoning. Clinical Experiences with 172 Children.\u201d Clinical Pediatrics 5 (9): 531\u201335.", "ArticleIdList": ["5911317"]}, {"Citation": "Yadav Reeta, Goldstein Sara, Nasef Mohamed O., Lee Wendy, and Samuni Uri. 2014. \u201cSynergistic Activity of Acetohydroxamic Acid on Prokaryotes under Oxidative Stress: The Role of Reactive Nitrogen Species.\u201d Free Radical Biology & Medicine 77 (December): 291\u201397.", "ArticleIdList": ["25261226"]}, {"Citation": "Yeatts Sharon D., Palesch Yuko Y., Moy Claudia S., and Selim Magdy. 2013. \u201cHigh Dose Deferoxamine in Intracerebral Hemorrhage (HI-DEF) Trial: Rationale, Design, and Methods.\u201d Neurocritical Care 19 (2): 257\u201366.", "ArticleIdList": ["PMC3932442", "23943316"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "29"}, {"Year": "2020", "Month": "8", "Day": "3"}, {"Year": "2020", "Month": "8", "Day": "9"}, {"Year": "2020", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2024", "Month": "4", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32828952", "NIHMS1622905", "PMC11059783", "10.1016/j.freeradbiomed.2020.08.004", "S0891-5849(20)31199-0"]}}], "PubmedBookArticle": []}